OppenheimerFunds’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $21.8M | Buy |
417,512
+23,578
| +6% | +$1.23M | 0.03% | 511 |
|
|
2018
Q4 | $18.8M | Buy |
393,934
+60,088
| +18% | +$2.87M | 0.03% | 531 |
|
|
2018
Q3 | $16.8M | Buy |
+333,846
| New | +$16.8M | 0.02% | 627 |
|
|
2017
Q4 | – | Sell |
-703,466
| Closed | -$35.7M | – | 1853 |
|
|
2017
Q3 | $35.7M | Buy |
703,466
+187,398
| +36% | +$9.51M | 0.04% | 389 |
|
|
2017
Q2 | $27.8M | Buy |
516,068
+120,869
| +31% | +$6.51M | 0.03% | 450 |
|
|
2017
Q1 | $20.8M | Buy |
395,199
+315,965
| +399% | +$16.7M | 0.03% | 568 |
|
|
2016
Q4 | $3.81M | Buy |
79,234
+20,380
| +35% | +$981K | ﹤0.01% | 856 |
|
|
2016
Q3 | $3.17M | Sell |
58,854
-12
| -0% | -$647 | ﹤0.01% | 855 |
|
|
2016
Q2 | $3.19M | Buy |
58,866
+16,521
| +39% | +$895K | ﹤0.01% | 838 |
|
|
2016
Q1 | $2.15M | Sell |
42,345
-473,943
| -92% | -$24M | ﹤0.01% | 882 |
|
|
2015
Q4 | $26M | Sell |
516,288
-606,152
| -54% | -$30.6M | 0.03% | 491 |
|
|
2015
Q3 | $27M | Buy |
1,122,440
+284,608
| +34% | +$6.84M | 0.04% | 460 |
|
|
2015
Q2 | $43.6M | Sell |
837,832
-30,084
| -3% | -$1.57M | 0.05% | 384 |
|
|
2015
Q1 | $50.1M | Buy |
867,916
+25,644
| +3% | +$1.48M | 0.06% | 374 |
|
|
2014
Q4 | $45M | Buy |
842,272
+275,244
| +49% | +$14.7M | 0.05% | 378 |
|
|
2014
Q3 | $32.6M | Buy |
567,028
+26,008
| +5% | +$1.49M | 0.04% | 451 |
|
|
2014
Q2 | $36.2M | Buy |
541,020
+20,020
| +4% | +$1.34M | 0.04% | 427 |
|
|
2014
Q1 | $34.8M | Buy |
521,000
+16,040
| +3% | +$1.07M | 0.04% | 429 |
|
|
2013
Q4 | $33.7M | Buy |
504,960
+68,580
| +16% | +$4.58M | 0.04% | 436 |
|
|
2013
Q3 | $27.4M | Buy |
436,380
+380
| +0.1% | +$23.8K | 0.04% | 461 |
|
|
2013
Q2 | $27.2M | Buy |
+436,000
| New | +$27.2M | 0.04% | 453 |
|